









Markets
/
Stocks
/
nasdaq-pbm
/

Psyence Biomedical Ltd

PBM

4.760USD

-0.540-10.19%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

106.63KMarket Cap

LossP/E TTM



Psyence Biomedical Ltd

4.760

-0.540-10.19%

Overview Company Financials Analysis

Income Statement

Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q4

FY2024Q2

Total equity

Cash, cash equivalents and short-term investments

--992.52K

--599.09K

- Cash and cash equivalents

--992.52K

--599.09K

Receivables

--56.51K

--18.71K

-Other receivables

--56.51K

--18.71K

Prepaid expenses

--436.06K

--15.45K

Other current assets

--40.08K

--33.31K

Total current assets

--1.53M

--666.56K

Non-current assets

Net Fixed Assets

--7.43K

----

Total non-current assets

--7.43K

----

Total assets

--1.53M

--666.56K

Liabilities

Current liabilities

-Other payables

--3.78M

----

Short-term debt and lease liabilities

--10.37M

--733.96K

-Short-term debt

--10.37M

--733.96K

Other current liabilities

--3.78M

----

Total current liabilities

--16.39M

--1.65M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

--0.00

Total liabilities

--16.39M

--1.65M

Shareholders' equity

Common equity

--62.44M

----

Retained earnings

---77.78M

----

Total equity

---14.85M

---978.55K

Currency unit

USD

USD

Audit opinions

--

--

KeyAI

